AUG 20, 2019 3:30 PM PDT

What's the Difference Between Therapy and MDMA Therapy?

WRITTEN BY: Annie Lennon

From a first glance, MDMA-assisted therapy may look very different from mainstream therapies such as Cognitive Behavioral Therapy (CBT); patients lying on a futon for up to eight hours with eye-shades and earphones for music flanked by both a male and female therapist. However, a closer look at this therapeutic practice shows that it indeed carries many similar traits to more conventional psychotherapy. So how similar are they? 

As with any other therapy, the course of MDMA-assisted therapy is governed by the patient’s innate desire and capability of healing, with the facilitation and guidance of their therapists. In MDMA-psychotherapy however, the pharmacological effects of MDMA occur in conjunction with psychotherapeutic treatment, typically acting as a catalyst towards healing. This of course means that, although many of the basic principles of psychotherapy are maintained, such as establishing a safe and supportive therapeutic setting as well as a mindset conducive to healing, there are some differences in how the treatment roles out (Mithoefer: 2015). 

As MDMA is known for making patients feel more at ease in social scenarios, more trusting and less emotionally volatile, it means that people undergoing treatment with MDMA are usually able to establish a rapport with their therapists from which progress can be made, known as a therapeutic alliance, much faster than with other treatments (Lennon: 2019). For example, with CBT, the recommended time for building a therapeutic alliance with patients is 9-12 weeks, with a chance of diminishing returns the longer the patient is unable to form a bond with the therapist. With MDMA-assisted therapy however, the timeframe for building a bond with the therapist is much shorter. The heightened attention in providing a comfortable physical and emotional environment in MDMA-assisted therapy coupled with the psychoactive effects of MDMA in promoting trust, a therapeutic alliance may easily develop within the first 4-6 weeks of treatment, if not before (Lennon: 2019). 

Moreover, the effects of MDMA also mean that cognitive restructuring (the identification of irrational thoughts and their solution) usually happens spontaneously in patients. This means that time is saved by both the therapist and the patient in recognising and deconstructing these verbally via the Socratic method as in CBT. It has also been observed that early experience of abuse or lack of support tend to spontaneously come up in MDMA-assisted therapies, alongside insight about their relationship with the patient’s psychological issues. Moreover, unlike in other methods more reliant on the therapist to bring these issues to light, this happens with little to no intervention. This means that, rather than needing to assign the patient homework to mentaly reframe and override certain emotionally triggering situations as in CBT, as the patient is confronted by their trauma mentally from MDMA, they are able to discuss it intermittently as it happens with their therapist during their session, reducing the time needed for the desired effect (Mithoefer: 2015). 

To conclude, although traditional therapies and MDMA-assisted therapy share many of the same goals, the way and speed at which they are achieved differs due to MDMA’s role as a catalyst. Whether it’s in building a therapeutic alliance or identifying irrational beliefs and trauma, MDMA appears to grant more agency to the patient in gaining a more profound understanding of themselves, meaning the therapist can take a slightly more passive role as a facilitator, rather than a teacher. 

 

Sources:



Mithoefer, Michael C.: MAPS: A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder 

Lennon, Annie: Labroots: "How Does Ecstasy Cure PTSD?"

Lennon, Annie: Labroots: "What Does MDMA Therapy Look Like?"

 

About the Author
  • Annie graduated from University College London and began traveling the world. She is currently a writer with keen interests in genetics, psychology and neuroscience; her current focus on the interplay between these fields to understand how to create meaningful interactions and environments.
You May Also Like
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Diabetic Drug Increasces Risk of Heart Complications
A drug by the name of ‘rosiglitazone’ used to treat type 2 diabetes was found to be associated with increased risk of heart problems, especiall...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headlines: blood containing antibodies from...
MAR 31, 2020
Cancer
MAR 31, 2020
Ovarian cancer metastasis and CPT1A
Research published in the journal Molecular Cancer Research from collaborators at the University of Colorado Cancer Center hits on new insight as...
Loading Comments...